rs202068245

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015375.3(DSTYK):​c.53C>T​(p.Pro18Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000423 in 1,585,060 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00047 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00042 ( 2 hom. )

Consequence

DSTYK
NM_015375.3 missense

Scores

2
2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.983

Publications

0 publications found
Variant links:
Genes affected
DSTYK (HGNC:29043): (dual serine/threonine and tyrosine protein kinase) This gene encodes a dual serine/threonine and tyrosine protein kinase which is expressed in multiple tissues. It is thought to function as a regulator of cell death. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
DSTYK Gene-Disease associations (from GenCC):
  • congenital anomalies of kidney and urinary tract 1
    Inheritance: AD, AR Classification: DEFINITIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • hereditary spastic paraplegia 23
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Orphanet
  • complex hereditary spastic paraplegia
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006824583).
BP6
Variant 1-205211483-G-A is Benign according to our data. Variant chr1-205211483-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 224358.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000473 (72/152334) while in subpopulation AMR AF = 0.000261 (4/15314). AF 95% confidence interval is 0.0000886. There are 0 homozygotes in GnomAd4. There are 38 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DSTYKNM_015375.3 linkc.53C>T p.Pro18Leu missense_variant Exon 1 of 13 ENST00000367162.8 NP_056190.1 Q6XUX3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DSTYKENST00000367162.8 linkc.53C>T p.Pro18Leu missense_variant Exon 1 of 13 1 NM_015375.3 ENSP00000356130.3 Q6XUX3-1
DSTYKENST00000367161.7 linkc.53C>T p.Pro18Leu missense_variant Exon 1 of 12 1 ENSP00000356129.3 Q6XUX3-2

Frequencies

GnomAD3 genomes
AF:
0.000473
AC:
72
AN:
152216
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.0164
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000915
AC:
184
AN:
201072
AF XY:
0.000909
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000222
Gnomad ASJ exome
AF:
0.0168
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000213
Gnomad OTH exome
AF:
0.00157
GnomAD4 exome
AF:
0.000417
AC:
598
AN:
1432726
Hom.:
2
Cov.:
32
AF XY:
0.000418
AC XY:
297
AN XY:
711326
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32348
American (AMR)
AF:
0.000210
AC:
9
AN:
42816
Ashkenazi Jewish (ASJ)
AF:
0.0161
AC:
409
AN:
25478
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38340
South Asian (SAS)
AF:
0.0000120
AC:
1
AN:
83654
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
43312
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5622
European-Non Finnish (NFE)
AF:
0.0000853
AC:
94
AN:
1101834
Other (OTH)
AF:
0.00143
AC:
85
AN:
59322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
40
80
120
160
200
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000473
AC:
72
AN:
152334
Hom.:
0
Cov.:
33
AF XY:
0.000510
AC XY:
38
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41582
American (AMR)
AF:
0.000261
AC:
4
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.0164
AC:
57
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68022
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00152
Hom.:
0
Bravo
AF:
0.000540
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000717
AC:
6
ExAC
AF:
0.000518
AC:
61

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DSTYK: BS1 -

Aug 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Congenital anomalies of kidney and urinary tract 1 Uncertain:1
-
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

DSTYK-related disorder Benign:1
Jun 27, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.13
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Benign
0.016
.;T
Eigen
Benign
-0.12
Eigen_PC
Benign
0.011
FATHMM_MKL
Benign
0.34
N
LIST_S2
Benign
0.78
T;T
M_CAP
Pathogenic
0.60
D
MetaRNN
Benign
0.0068
T;T
MetaSVM
Benign
-0.51
T
MutationAssessor
Benign
1.0
L;L
PhyloP100
0.98
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-0.18
N;N
REVEL
Benign
0.24
Sift
Uncertain
0.012
D;D
Sift4G
Benign
0.31
T;T
Polyphen
0.40
B;B
Vest4
0.30
MVP
0.55
MPC
0.39
ClinPred
0.086
T
GERP RS
4.3
PromoterAI
0.11
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.062
gMVP
0.36
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202068245; hg19: chr1-205180611; COSMIC: COSV65686225; API